How Smaller Managers are Navigating the Evolving Investment Landscape (Hedge Week)
Traditionally, allocators and investors often eschewed smaller, specialist hedge funds in favour of the firepower offered by larger brand-name managers. But as many smaller funds have posted outsized gains in recent years – while well-established marquee names experienced decidedly mixed performances – many at the forefront of the industry are detecting a potentially decisive shift in investor sentiment. Squeezed returns – along with fee pressures, investor outflows, increased transparency, greater operational due diligence, and a growth in rival products such as private equity – have thrown up challenges to hedge fund strategies of all stripes and sizes, shifting the balance of power from managers to investors.
Uniqure Nv (QURE) CEO, CFO, Managing Director Matthew C Kapusta Sold $3.3 million of Shares (Guru Focus)
CEO, CFO, Managing Director of Uniqure Nv, Matthew C Kapusta, sold 51,872 shares of QURE on 01/28/2020 at an average price of $63.9 a share. The total sale was $3.3 million. uniQure NV is engaged in the field of gene therapy platform across three therapeutic focus areas: Liver/Metabolic Disease, Central Nervous System (CNS) Disease and Cardiovascular Disease.
Wednesday 1/29 Insider Buying Report: CADE, ZYME (Nasdaq.com)
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys. On Monday, Cadence Bancorporation’s Director, Marc J. Shapiro, made a $403,250 purchase of CADE, buying 25,000 shares at a cost of $16.13 a piece. Cadence Bancorporation is trading up about 1.3% on the day Wednesday. This buy marks the first one filed by Shapiro in the past twelve months.
Sebi Disposes of Insider Trading Case Against Gammon Infra’s Former CMD (Business Insider)
New Delhi, Jan 29 () Markets regulator Sebi has disposed of adjudicating proceedings against Abhijit Rajan, former chairman of Gammon Infrastructure Projects, in an alleged insider trading case. It was alleged that Rajan violated the code of corporate disclosure practices under prevention of insider trading norms. “I conclude the allegations levelled in the said SCN (show cause notice) against the noticee i.e Abhijit Rajan does not stand established,” Sebi Adjudicating Officer Sangeeta Rathod said in an order passed on Tuesday.
The CAO of Home Bancshares (NASDAQ: HOMB) is Selling Shares (Analyst Ratings)
Today, the CAO of Home Bancshares (HOMB), Jennifer Floyd, sold shares of HOMB for $32.19K. Based on Home Bancshares’ latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $203 million and quarterly net profit of $73.26 million.
